<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Recently, a high incidence of novel N-glycosylation sites introduced by <z:hpo ids='HP_0001428'>somatic mutation</z:hpo> was observed in the immunoglobulin variable region genes of follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>As these are positively selected and are uncommon in <z:mpath ids='MPATH_458'>normal</z:mpath> B cells, they may have a role in <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumour growth</z:e> and behaviour </plain></SENT>
<SENT sid="2" pm="."><plain>Sites are not characteristic of <z:hpo ids='HP_0011010'>chronic</z:hpo> lymphocytic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> or <z:mp ids='MP_0009440'>myeloma</z:mp>, but are detectable in approximately 50% of diffuse large cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Another feature of the variable region genes of certain <z:hpo ids='HP_0002665'>lymphomas</z:hpo> is ongoing <z:hpo ids='HP_0001428'>somatic mutation</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>To determine whether glycosylation is associated with this phenomenon, we analysed variable region gene sequences of Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) and mucosa-associated lymphoid tissue (MALT) <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Novel sites were common in endemic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> (82%) and in 4/5 patients with Iranian <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>However, <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> had a lower incidence (43%) </plain></SENT>
<SENT sid="7" pm="."><plain>Patients with MALT <z:hpo ids='HP_0002665'>lymphoma</z:hpo> had a low frequency (9%) of novel sites, comparable to <z:mpath ids='MPATH_458'>normal</z:mpath> B cells </plain></SENT>
<SENT sid="8" pm="."><plain>These findings distinguish glycosylation sites from ongoing mutation and may reflect different environmental influences on these <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> </plain></SENT>
</text></document>